Division of Vascular and Endovascular Surgery, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Tex.
Division of Vascular and Endovascular Surgery, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Tex.
J Vasc Surg. 2015 Jan;61(1):80-7. doi: 10.1016/j.jvs.2014.06.113. Epub 2014 Aug 2.
Fenestrated endovascular aortic aneurysm repair (FEVAR) is an alternative to open repair in patients with complex abdominal aortic aneurysms who are neither fit nor suitable for standard open or endovascular repair. Chimney and snorkel grafts are other endovascular alternatives but frequently require bilateral upper extremity access that has been associated with a 3% to 10% risk of stroke. However, upper extremity access is also frequently required for FEVAR because of the caudal orientation of the visceral vessels. The purpose of this study was to assess the use of upper extremity access for FEVAR and the associated morbidity.
During a 5-year period, 148 patients underwent FEVAR, and upper extremity access for FEVAR was used in 98 (66%). Outcomes were compared between those who underwent upper extremity access and those who underwent femoral access alone. The primary end point was a cerebrovascular accident or transient ischemic attack, and the secondary end point was local access site complications. The mean number of fenestrated vessels was 3.07 ± 0.81 (median, 3) for a total of 457 vessels stented. Percutaneous upper extremity access was used in 12 patients (12%) and open access in 86 (88%). All patients who required a sheath size >7F underwent high brachial open access, with the exception of one patient who underwent percutaneous axillary access with a 12F sheath. The mean sheath size was 10.59F ± 2.51F (median, 12F), which was advanced into the descending thoracic aorta, allowing multiple wire and catheter exchanges.
One hemorrhagic stroke (one of 98 [1%]) occurred in the upper extremity access group, and one ischemic stroke (one of 54 [2%]) occurred in the femoral-only access group (P = .67). The stroke in the upper extremity access group occurred 5 days after FEVAR and was related to uncontrolled hypertension, whereas the stroke in the femoral group occurred on postoperative day 3. Neither patient had signs or symptoms of a stroke immediately after FEVAR. The right upper extremity was accessed six times without a stroke (0%) compared with the left being accessed 92 times with one stroke (1%; P = .8). Four patients (4%) had local complications related to upper extremity access. One (1%) required exploration for an expanding hematoma after manual compression for a 7F sheath, one (1%) required exploration for hematoma and neurologic symptoms after open access for a 12F sheath, and two patients (2%) with small hematomas did not require intervention. Two (two of 12 [17%]) of these complications were in the percutaneous access group, which were significantly more frequent than in the open group (two of 86 [2%]; P = .02).
Upper extremity access appears to be a safe and feasible approach for patients undergoing FEVAR. Open exposure in the upper extremity may be safer than percutaneous access during FEVAR. Unlike chimney and snorkel grafts, upper extremity access during FEVAR is not associated with an increased risk of stroke, despite the need for multiple visceral vessel stenting.
在不适合接受标准开放或血管内修复的复杂腹主动脉瘤患者中,开窗血管内主动脉瘤修复术(FEVAR)是一种替代开放修复的方法。烟囱和通气管移植物是其他血管内替代方法,但通常需要双侧上肢入路,这与 3%至 10%的中风风险相关。然而,由于内脏血管的尾向位置,FEVAR 也经常需要上肢入路。本研究的目的是评估上肢入路在 FEVAR 中的应用及其相关并发症。
在 5 年期间,148 例患者接受了 FEVAR,其中 98 例(66%)采用了上肢入路。比较了上肢入路组和单纯股动脉入路组的结局。主要终点是脑血管意外或短暂性脑缺血发作,次要终点是局部入路并发症。共支架 457 个,平均开窗血管数为 3.07±0.81(中位数 3)。12 例(12%)采用经皮上肢入路,86 例(88%)采用开放入路。所有需要鞘管尺寸大于 7F 的患者均接受高肱动脉开放入路,除 1 例采用 12F 鞘管的经腋动脉经皮入路外。平均鞘管尺寸为 10.59F±2.51F(中位数 12F),可推进至降主动脉,允许多次导丝和导管交换。
上肢入路组发生 1 例出血性中风(98 例中 1 例[1%]),单纯股动脉入路组发生 1 例缺血性中风(54 例中 1 例[2%])(P=0.67)。上肢入路组的中风发生在 FEVAR 后 5 天,与未控制的高血压有关,而股动脉组的中风发生在术后第 3 天。在 FEVAR 后,两组患者均无中风的症状或体征。右侧上肢入路 6 次无中风(0%),左侧入路 92 次有 1 次中风(1%)(P=0.8)。4 例(4%)患者发生与上肢入路相关的局部并发症。1 例(1%)因 7F 鞘管手动压迫后血肿扩大需要探查,1 例(1%)因 12F 鞘管开放后血肿和神经症状需要探查,2 例(2%)小血肿患者无需干预。这 2 例(12 例中的 2 例[17%])并发症发生在经皮入路组,明显高于开放组(86 例中的 2 例[2%];P=0.02)。
上肢入路似乎是 FEVAR 患者安全可行的方法。在 FEVAR 期间,上肢的开放性暴露可能比经皮入路更安全。与烟囱和通气管移植物不同,尽管需要对多个内脏血管进行支架置入,但上肢入路在 FEVAR 中并不增加中风的风险。